Vinod K. Rustgi
- Hepatology top 0.02%
- Hepatitis C virus research 71
- Liver Disease and Transplantation 47
- Liver Diseases and Immunity 9
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Epidemiology top 0.05%
- Liver Disease Diagnosis and Treatment 89
- Hepatitis B Virus Studies 44
- Infectious Diseases top 0.5%
- Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research 12
- Virology top 2%
-
- Organ Transplantation Techniques and Outcomes 17
- Co-authors
- Stuart C. GordonMitchell L. ShiffmanJanice K. AlbrechtJohn G. McHutchisonZachary GoodmanRobert ReindollarMichael P. MannsKenneth Koury
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Vinod K. Rustgi
165 papers receiving 13.3k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Hepatology 11.9k
- Epidemiology 10.7k
- Infectious Diseases 1.6k
- Rheumatology 1.2k
- Virology 242
Countries citing papers authored by Vinod K. Rustgi
This map shows the geographic impact of Vinod K. Rustgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinod K. Rustgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinod K. Rustgi more than expected).
Fields of papers citing papers by Vinod K. Rustgi
This network shows the impact of papers produced by Vinod K. Rustgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinod K. Rustgi. The network helps show where Vinod K. Rustgi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vinod K. Rustgi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 10 | |
| 8 | 2021 | 22 | |
| 9 | 2020 | 25 | |
| 10 | 2014 | 4 | |
| 11 | Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients >= 65 Years of Age: Results From Phase 2 and 3 Trials | 2014 | 4 |
| 12 | 2013 | 86 | |
| 13 | 2012 | 4 | |
| 14 | 2009 | 2 | |
| 15 | 2007 | 6 | |
| 16 | 2004 | 29 | |
| 17 | 2004 | 13 | |
| 18 | 2002 | 5 | |
| 19 | Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis Cbreakdown → | 1998 | 1070 |
| 20 | 1994 | 91 |
About Vinod K. Rustgi
Vinod K. Rustgi is a scholar working on Hepatology, Epidemiology and Transplantation, having authored 173 papers that have together received 13.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (89 papers), Hepatitis C virus research (71 papers), Liver Disease and Transplantation (47 papers), Hepatitis B Virus Studies (44 papers), Organ Transplantation Techniques and Outcomes (17 papers), Systemic Lupus Erythematosus Research (12 papers), Liver Diseases and Immunity (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). The work is most often cited by research in Hepatology (11.9k citations), Epidemiology (10.7k citations) and Infectious Diseases (1.6k citations). Vinod K. Rustgi has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Stuart C. Gordon, Mitchell L. Shiffman, Janice K. Albrecht, John G. McHutchison, Zachary Goodman, Robert Reindollar, Michael P. Manns, Kenneth Koury, William M. Lee and Eugene R. Schiff. Their work appears in journals such as Clinics in Liver Disease, Gastroenterology, Hepatology, Journal of Hepatology and The American Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.